The Non-Activated Thromboelastometry (NATEM) Assay's Application among Adults and Neonatal/Pediatric Population: A Systematic Review
- PMID: 35328210
- PMCID: PMC8947108
- DOI: 10.3390/diagnostics12030658
The Non-Activated Thromboelastometry (NATEM) Assay's Application among Adults and Neonatal/Pediatric Population: A Systematic Review
Abstract
The non-activated thromboelastometry (NATEM) assay is a point-of-care assay that can provide a comprehensive insight into the actual hemostatic mechanism. However, there are very limited data about its use in clinical practice. The aim of this study was to systematically review the literature for any data regarding the use of NATEM in several clinical settings. A systematic review of PubMed and Scopus databases was conducted through 20 January 2022 for studies evaluating the use of the NATEM assay in different clinical settings. The literature search yielded a total of 47 publications, 30 of which met the eligibility criteria for this review. Evaluation of NATEM's detecting ability for hemostasis disorders is limited in the literature. The results of the included studies indicate that NATEM seems to be a sensitive method for the detection of hyperfibrinolysis and may have an advantage in the diagnosis of hemostatic disorders. It could be more informative than the other ROTEM assays for detecting changes in coagulation parameters in patients who receive anticoagulants. However, the reported outcomes are highly varying among the included studies. NATEM has a high sensitivity to detect hypo- or hypercoagulability and provides a detailed insight into the whole hemostatic process from clot formation to clot breakdown. It could be a useful technique in variable fields of medicine, not only in adults, but also in pediatric and neonatal populations, to guide different hemostatic treatments and predict coagulation disorders or mortality/morbidity; this issue remains to be further investigated.
Keywords: NATEM; ROTEM; hemostasis; neonates; non-activated thromboelastometry; thromboelastometry.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates.Semin Thromb Hemost. 2023 Mar;49(2):182-191. doi: 10.1055/s-0042-1753513. Epub 2022 Sep 2. Semin Thromb Hemost. 2023. PMID: 36055275
-
Reference Values of Thromboelastometry Parameters in Healthy Term Neonates Using NATEM in Cord Blood Samples.Children (Basel). 2022 Jan 2;9(1):47. doi: 10.3390/children9010047. Children (Basel). 2022. PMID: 35053672 Free PMC article.
-
Hemostatic Profile of Intrauterine Growth-Restricted Neonates: Assessment with the Use of NATEM Assay in Cord Blood Samples.Diagnostics (Basel). 2024 Jan 13;14(2):178. doi: 10.3390/diagnostics14020178. Diagnostics (Basel). 2024. PMID: 38248055 Free PMC article.
-
Neurosurgical applications of viscoelastic hemostatic assays.Neurosurg Focus. 2017 Nov;43(5):E9. doi: 10.3171/2017.8.FOCUS17447. Neurosurg Focus. 2017. PMID: 29088950 Review.
-
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature.Semin Thromb Hemost. 2024 Mar;50(2):169-181. doi: 10.1055/s-0043-1762893. Epub 2023 Feb 17. Semin Thromb Hemost. 2024. PMID: 36807290
Cited by
-
Sepsis Induced Coagulopathy: Bringing Science to the Bedside.Indian J Crit Care Med. 2023 Sep;27(9):611-612. doi: 10.5005/jp-journals-10071-24537. Indian J Crit Care Med. 2023. PMID: 37719344 Free PMC article.
-
Severe Hereditary Hypofibrinogenemia in Pregnancy: A Case Report of a Novel Obstetrical Management with Thromboelastometry Guided Fibrinogen Supplementation.Diagnostics (Basel). 2025 Jun 30;15(13):1671. doi: 10.3390/diagnostics15131671. Diagnostics (Basel). 2025. PMID: 40647670 Free PMC article.
-
The Proteome of Extracellular Vesicles Released from Pulmonary Microvascular Endothelium Reveals Impact of Oxygen Conditions on Biotrauma.Int J Mol Sci. 2024 Feb 19;25(4):2415. doi: 10.3390/ijms25042415. Int J Mol Sci. 2024. PMID: 38397093 Free PMC article.
-
Hemostatic capability of ultrafiltrated fresh frozen plasma compared to cryoprecipitate.Sci Rep. 2023 Dec 7;13(1):21579. doi: 10.1038/s41598-023-48759-1. Sci Rep. 2023. PMID: 38062086 Free PMC article.
-
Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers, and Current Guidelines.Life (Basel). 2023 Jan 28;13(2):350. doi: 10.3390/life13020350. Life (Basel). 2023. PMID: 36836706 Free PMC article. Review.
References
-
- Bugaev N., Como J.J., Golani G., Freeman J.J., Sawhney J.S., Vatsaas C.J., Yorkgitis B.K., Kreiner L.A., Garcia N.M., Aziz H.A., et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: Practice management guideline from the Eastern Association for the Surgery of Trauma. J. Trauma Acute Care Surg. 2020;89:999–1017. doi: 10.1097/TA.0000000000002944. - DOI - PubMed
-
- Da Luz L.T., Nascimento B., Shankarakutty A.K., Rizoli S., Adhikari N.K. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: Descriptive systematic review. Crit. Care. 2014;18:518. doi: 10.1186/s13054-014-0518-9. - DOI - PMC - PubMed
-
- Görlinger K., Dirkmann D., Hanke A.A. Rotational Thromboelastometry (ROTEM®) In: Gonzalez E., Moore H.B., Moore E.E., editors. Trauma Induced Coagulopathy. Springer International Publishing; Cham, Switzerland: 2016. pp. 267–298. - DOI
-
- Simurda T., Asselta R., Zolkova J., Brunclikova M., Dobrotova M., Kolkova Z., Loderer D., Skornova I., Hudecek J., Lasabova Z., et al. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management. Diagnostics. 2021;11:2140. doi: 10.3390/diagnostics11112140. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous